**Question:** All of the following genes are implicated in colon carcinoma by classical pathway except

A. APC
B. RAS
C. TP53
D. KRAS

**Correct Answer:** **D. KRAS**

**Core Concept:**
Colon carcinoma is a type of cancer that develops in the colon, part of the large intestine. The development of colon carcinoma involves multiple genes and pathways, including the classical pathway. The classical pathway is a part of the cell signaling process, which leads to cell growth and division. Four key genes implicated in colon carcinoma by the classical pathway are:

1. **APC (Adenomatous Polyposis Coli)**: A tumor suppressor gene that plays a crucial role in maintaining cell polarity, regulating cell proliferation, and promoting apoptosis (programmed cell death). Mutations in this gene lead to uncontrolled cell growth and the development of colon polyps and eventually colon carcinoma.
2. **RAS (Rat Sarcoma)**: A family of genes encoding proteins involved in cell growth control. Mutations in RAS genes (KRAS, NRAS, and HRAS) can lead to uncontrolled cell growth and promote colon carcinoma development.
3. **TP53 (Tumor Protein P53)**: A tumor suppressor gene that regulates cell cycle progression, DNA repair, and apoptosis. Mutations in TP53 gene result in loss of its functions, leading to uncontrolled cell growth and the development of colon carcinoma.
4. **BRAF (B-Raf proto-oncogene)**: A gene encoding a protein that participates in the mitogen-activated protein kinase (MAPK) signaling pathway. Mutations in BRAF gene are less common in colon carcinoma compared to other genes mentioned.

**Why the Correct Answer is D. KRAS:**

The correct answer, KRAS, is a member of the RAS family of genes. Mutations in KRAS, like other RAS genes (NRAS and HRAS), can lead to uncontrolled cell growth and promote colon carcinoma development. However, the specificity of KRAS mutation types (e.g., KRAS) differs from other RAS genes.

**Why Each Wrong Answer Is Incorrect:**

A. APC: Mutations in this gene are more common in colon carcinoma than KRAS. Although APC is crucial for regulating cell growth, its role differs from KRAS.

B. TP53: Mutations in TP53 are more common than KRAS and play a vital role in regulating cell growth, DNA repair, and apoptosis, unlike KRAS.

C. BRAF: Mutations in BRAF are less common compared to TP53 and APC, and their involvement in colon carcinoma development differs from KRAS.

**Why the Wrong Answers Are More Common:**

APC mutations are more common than KRAS mutations in colon carcinogenesis. TP53 mutations are more common than KRAS mutations. BRAF mutations are less common than TP53 and APC mutations.

**Core Clinical Relevance:**

Understanding the specific roles and frequencies of mutations in these genes is crucial for